PROSTAQRE, a food supplement indicated in the prevention and/or treatment of prostate cancer, as its active ingredient Sulforaphane possess the capacity to inhibit the malignant transformation of various cell types (prostate, breast , lung, colon, bladder, hepatocyte) and limit cancer progression after carcinogen exposure. PROSTAQRE has demonstrated its activity in a clinical trial showing a significant decrease in the PSA level which is of interest for men diagnosed with a prostate cancer, during active surveillance or after prostatectomy.